Distribution of extended-spectrum β-lactamases in clinical isolates of Enterobactetiaceae in Vietnam

被引:97
|
作者
Cao, V
Lambert, T
Nhu, DQ
Loan, HK
Hoang, NK
Arlet, G
Courvalin, P
机构
[1] Inst Pasteur, Unite Agents Antibacteriens, F-75724 Paris 15, France
[2] Ctr Etud Pharmaceut, Chatenay Malabry, France
[3] Hop Tenon, Serv Bacteriol, UFR St Antoine, F-75970 Paris 20, France
[4] Inst Pasteur Ho Chi Minh Ville, Ho Chi Minh City, Vietnam
关键词
D O I
10.1128/AAC.46.12.3739-3743.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Among 730 Escherichia coli, 438 Klebsiella pneumoniae, and 141 Proteus mirabilis isolates obtained between September 2000 and September 2001 in seven hospitals in Ho Chi Minh City, Vietnam, 26.6% were resistant to ceftazidime, 30% were resistant to cefotaxime, 31.5% were resistant to ceftriaxone, 15.9% were resistant to cefoperazone, and 6% were resistant to cefepime. Resistance to imipenem was found in 5.6% of the isolates. In 55 strains producing extended-spectrum beta-lactamases (32 E. coli isolates, 13 K. pneumoniae isolates, and 10 P. mirabilis isolates), structural genes for VEB-1 (25.5%), CTX-M (25.5%), SHV (38.1%), and TEM (76.3%) enzymes were detected alone or in combination. Sequencing of the PCR products obtained from the K. pneumoniae isolates revealed the presence of bla(VEB-1), bla(CTX-M-14), bla(CTX-M-17), bla(SHV-2), and bla(TEM.1). Molecular typing of the strains with a similar resistance phenotype to broad-spectrum cephalosporins indicated polyclonal spread. ISEcp1 was presumably responsible for dissemination of the bla(CTX-M-like) gene.
引用
收藏
页码:3739 / 3743
页数:5
相关论文
共 50 条
  • [41] Characterization and Molecular Epidemiology of Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacteriaceae in a Tunisian University Hospital
    Dahmen, Safia
    Bettaieb, Dalia
    Mansour, Wejden
    Boujaafar, Noureddine
    Bouallegue, Olfa
    Arlet, Guillaume
    MICROBIAL DRUG RESISTANCE, 2010, 16 (02) : 163 - 170
  • [42] AMINOGLYCOSIDE-MODIFYING ENZYMES IN CLINICAL ISOLATES HARBORING EXTENDED-SPECTRUM BETA-LACTAMASES
    FERNANDEZRODRIGUEZ, A
    CANTON, R
    PEREZDIAZ, JC
    MARTINEZBELTRAN, J
    PICAZO, JJ
    BAQUERO, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (11) : 2536 - 2538
  • [43] Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum β-lactamases
    Jones, G. Ll.
    Warren, R. E.
    Skidmore, S. J.
    Davies, V. A.
    Gibreel, T.
    Upton, M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1245 - 1251
  • [44] Extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella spp. in a Singapore hospital:: Clinical spectrum
    Chlebicki, MP
    Oh, HML
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2004, 33 (03) : 302 - 306
  • [45] Extended-spectrum Beta-lactamases A Brief Clinical Update
    Malloy, Allison M. W.
    Campos, Joseph M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (12) : 1092 - 1093
  • [47] Genetic support of extended-spectrum β-lactamases
    Poirel, L.
    Naas, T.
    Nordmann, P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 75 - 81
  • [48] Extended-spectrum beta-lactamases
    Philippon, A.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2013, 28 (5-6): : 287 - 296
  • [49] Extended-spectrum β-lactamases and the permeability barrier
    Martinez-Martinez, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 82 - 89
  • [50] Detection of extended-spectrum beta-lactamases and carbapenemases in clinical isolates of Stenotrophomonas maltophilia in the northeast of Iran
    Rizi, Kobra Salimiyan
    Jamehdar, Saeid Amel
    Sasan, Mohammad Saeed
    Ghazvini, Kiarash
    Aryan, Ehsan
    Safdari, Hadi
    Farsiani, Hadi
    GENE REPORTS, 2024, 34